Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1994-10-4
|
pubmed:abstractText |
Levofloxacin, the S-(-)-isomer of ofloxacin, was compared to ofloxacin and ciprofloxacin against > 6000 recent clinical isolates of Gram-positive and Gram-negative bacteria from six different countries. This international multicenter study demonstrated a high level of antibacterial activity of levofloxacin against all the members of Enterobacteriaceae [minimum inhibitory concentration (MIC)50s, < or = 0.03 to 0.12 mg/L] except Providencia rettgeri (MIC50, 2 mg/L), and Providencia stuartii (MIC50, 1 mg/L). Oxacillin-susceptible staphylococci (MIC50s, 0.12 to 0.25 mg/L), enterococci (MIC50s, 0.5 to 2 mg/L), and streptococci (MIC50s, 0.5 mg/L) were also susceptible to levofloxacin, but most isolates of oxacillin-resistant staphylococci had MICs of > or = 4 mg/L. Levofloxacin was also active against non-enteric Gram-negative bacilli, including Acinetobacter species (MIC50s, < or = 0.03 to 1 mg/L), Pseudomonas species (MIC50s, 0.5 to 1 mg/L) and Xanthomonas maltophilia (MIC50, 0.5 mg/L). Overall, levofloxacin inhibited 50% and 90% of all the tested strains at the concentrations of 0.12 and 4 mg/L, respectively. The activity of levofloxacin was generally two-fold greater than ofloxacin and equal to or slightly less potent than ciprofloxacin.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1120-009X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
83-91
|
pubmed:dateRevised |
2009-8-4
|
pubmed:meshHeading |
pubmed-meshheading:8077990-Asia,
pubmed-meshheading:8077990-Ciprofloxacin,
pubmed-meshheading:8077990-Europe,
pubmed-meshheading:8077990-Gram-Negative Bacteria,
pubmed-meshheading:8077990-Gram-Positive Bacteria,
pubmed-meshheading:8077990-Humans,
pubmed-meshheading:8077990-Microbial Sensitivity Tests,
pubmed-meshheading:8077990-North America,
pubmed-meshheading:8077990-Ofloxacin,
pubmed-meshheading:8077990-South America
|
pubmed:year |
1994
|
pubmed:articleTitle |
Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin.
|
pubmed:affiliation |
Department of Laboratory Medicine, Kumamoto University Medical School, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Multicenter Study
|